Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13500 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Intervention: Drug: fludarabine phosphate
2 Active, not recruiting Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: FOLFOX or;   Drug: FOLFIRI
3 Completed Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Intervention: Other: There is no intervention in this study.
4 Completed Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Condition: Hypertension
Interventions: Drug: Irbesartan/HCTZ;   Drug: Irbesartan monotherapy;   Drug: HCTZ monotherapy
5 Completed PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis C, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]
6 Terminated
Has Results
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Condition: Schizophrenia and Disorders With Psychotic Features
Intervention: Drug: Ziprasidone HCL (oral)
7 Completed LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Condition: Hyperlipidemia
Interventions: Biological: evolocumab (AMG 145);   Other: Ezetimibe;   Other: Placebo (administered subcutaneously);   Other: Placebo (administered orally);   Drug: Atorvastatin;   Drug: Rosuvastatin;   Drug: Simvastatin
8 Completed A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GSK1605786A;   Drug: Placebo
9 Completed Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Colorectal Cancer;   Quality of Life
Interventions: Biological: cetuximab;   Procedure: quality-of-life assessment
10 Terminated
Has Results
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
11 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
12 Completed Genetic Study in Patients With Stage II or Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Genetic: DNA stability analysis;   Genetic: gene mapping
13 Completed Open Label Extension Study of PREOS
Condition: Osteoporosis
Intervention: Drug: ALX1-11 (drug)
14 Completed Canadian Active & Maintenance Modified Pentasa Study
Conditions: Active Ulcerative Colitis;   Remission of Ulcerative Colitis
Intervention: Drug: 5-ASA (5-Aminosalicylate)
15 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
16 Completed
Has Results
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Dapagliflozin placebo;   Drug: Metformin
17 Completed
Has Results
A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
18 Active, not recruiting
Has Results
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: docetaxel;   Drug: lapatinib ditosylate;   Drug: paclitaxel
19 Completed Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
Condition: Heart Failure, Congestive
Interventions: Device: Optimal Medical Therapy plus ICD;   Device: Optimal Medical Therapy plus CRT/ICD
20 Unknown  Eligard Observational Registry for Patients With Prostate Cancer
Condition: Cancer of the Prostate
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years